Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value ($000): $193,700 (100.0% shares, 0.0% debt)

Holdings (35)

HANGER INC 11.6%
Value ($000) $22,539 Shares 1,189,399 Est. Cost $20.83 Unrealized
REATA PHARMACEUTICALS INC 7.3%
Value ($000) $14,193 Shares 253,000 Est. Cost $46.26 Unrealized
CI CIGNA CORP NEW 7.2%
Value ($000) $13,921 Shares 73,300 Est. Cost $190.77 Unrealized 0.0%
WELLCARE HEALTH PLANS INC 6.1%
Value ($000) $11,805 Shares 50,000 Est. Cost $236.10 Unrealized
ARENA PHARMACEUTICALS INC 5.6%
Value ($000) $10,814 Shares 277,650 Est. Cost $42.17 Unrealized
ZBH ZIMMER BIOMET HLDGS INC 5.5%
Value ($000) $10,723 Shares 103,380 Est. Cost $109.70 Unrealized -3.3%
IOVA IOVANCE BIOTHERAPEUTICS INC 4.9%
Value ($000) $9,403 Shares 1,062,500 Est. Cost $11.58 Unrealized -16.7%
BMRN BIOMARIN PHARMACEUTICAL INC 4.5%
Value ($000) $8,770 Shares 103,000 Est. Cost $91.65 Unrealized +3.8%
ALLERGAN PLC 4.2%
Value ($000) $8,207 Shares 61,400 Est. Cost $148.96 Unrealized
ALBIREO PHARMA INC 3.4%
Value ($000) $6,627 Shares 270,146 Est. Cost $29.61 Unrealized
ASSEMBLY BIOSCIENCES INC 3.2%
Value ($000) $6,242 Shares 275,941 Est. Cost $29.40 Unrealized
GLPG GALAPAGOS NV 3.0%
Value ($000) $5,766 Shares 62,850 Est. Cost $91.74 Unrealized
INTEC PHARMA LTD JERUSALEM 2.6%
Value ($000) $5,098 Shares 676,104 Est. Cost $4.60 Unrealized
TELIGENT INC NEW 2.5%
Value ($000) $4,860 Shares 3,547,607 Est. Cost $3.21 Unrealized
ASGN ASGN INC 2.5%
Value ($000) $4,780 Shares 87,700 Est. Cost $65.19 Unrealized 0.0%
VKTX VIKING THERAPEUTICS INC 2.5%
Value ($000) $4,774 Shares 624,000 Est. Cost $11.93 Unrealized +0.2%
PROVIDENCE SVC CORP 2.4%
Value ($000) $4,699 Shares 78,298 Est. Cost $67.28 Unrealized
KURA KURA ONCOLOGY INC 2.3%
Value ($000) $4,445 Shares 316,581 Est. Cost $16.20 Unrealized -18.2%
AXGN AXOGEN INC 2.2%
Value ($000) $4,272 Shares 209,088 Est. Cost $35.82 Unrealized -12.7%
STRONGBRIDGE BIOPHARMA PLC 2.2%
Value ($000) $4,202 Shares 937,900 Est. Cost $4.65 Unrealized
CATALYST BIOSCIENCES INC 1.9%
Value ($000) $3,684 Shares 466,900 Est. Cost $9.35 Unrealized
SIERRA ONCOLOGY INC 1.7%
Value ($000) $3,371 Shares 2,553,943 Est. Cost $1.95 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 1.7%
Value ($000) $3,357 Shares 404,463 Est. Cost $10.25 Unrealized 0.0%
CNC CENTENE CORP DEL 1.5%
Value ($000) $2,883 Shares 25,000 Est. Cost $59.79 Unrealized +12.0%
MGNX MACROGENICS INC 1.3%
Value ($000) $2,465 Shares 194,129 Est. Cost $19.75 Unrealized -15.1%
EOLS EVOLUS INC 1.2%
Value ($000) $2,331 Shares 195,911 Est. Cost $19.50 Unrealized -26.9%
MILLENDO THERAPEUTICS INC 1.1%
Value ($000) $2,041 Shares 256,739 Est. Cost $7.95 Unrealized
LGND LIGAND PHARMACEUTICALS INC 0.9%
Value ($000) $1,710 Shares 12,600 Est. Cost $106.61 Unrealized 0.0%
TRIPLE-S MGMT CORP 0.6%
Value ($000) $1,139 Shares 65,515 Est. Cost $17.39 Unrealized
CLOVIS ONCOLOGY INC 0.6%
Value ($000) $1,079 Shares 60,100 Est. Cost $17.95 Unrealized
CERECOR INC 0.5%
Value ($000) $994 Shares 307,733 Est. Cost $3.23 Unrealized
PIERIS PHARMACEUTICALS INC 0.5%
Value ($000) $885 Shares 332,846 Est. Cost $5.76 Unrealized
OPTINOSE INC 0.4%
Value ($000) $870 Shares 140,314 Est. Cost $6.20 Unrealized
CIDARA THERAPEUTICS INC 0.3%
Value ($000) $578 Shares 245,764 Est. Cost $6.80 Unrealized
AQUINOX PHARMACEUTICALS INC 0.1%
Value ($000) $173 Shares 80,289 Est. Cost $2.50 Unrealized